IMPORTANT SAFETY INFORMATION
OMIDRIA® (phenylephrine and ketorolac injection) 1% / 0.3% must be added to irrigation solution prior
to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure of phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid,
phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past
medical history of asthma.
The most commonly reported adverse reactions at 2-24% are eye irritation, posterior capsule opacification,
increased intraocular pressure, and anterior chamber inflammation.
Use of OMIDRIA in children has not been established.
INDICATIONS AND USAGE
OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens
replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing
postoperative ocular pain.
Please see the Full Prescribing Information at www.omidria.com/
prescribinginformation.
Visit www.omidria.com
EXPERIENCE
THE POWER OF
PREEMPTION
LEARN MORE AT BOOTH #1117
OMEROS®, the OMEROS® logo, OMIDRIA®, and the OMIDRIA logo®
are registered trademarks of Omeros Corporation.
© Omeros Corporation 2016, all rights reserved. 2016-060
